Skip to main content

Children's Hospital Boston to Use Geospiza Software for Sequencing Data

NEW YORK (GenomeWeb News) – The Molecular Genetics Core Facility of Children’s Hospital Boston and Harvard Medical School will use Geospiza’s FinchLab to manage its genetic sequencing operations, the Seattle-based bioinformatics firm said today.
 
FinchLab is a web-based system designed to help researchers with data analysis and lab management across multiple platforms including capillary electrophoresis-based instruments and next-generation sequencing platforms, such as Applied Biosystems’ SOLiD, said Geospiza.
 
"We were looking for a way to provide access to our sequencing data through one location," said Hal Schneider, laboratory supervisor of the Molecular Genetics Core Facility, in a statement. He said that FinchLab “not only met our basic requirements, but also provided a whole package — from taking care of the server operations, tracking the samples, and then completing the alignments and essential analysis for SOLiD with a simple data distribution method."
 
Terms of the agreement were not disclosed.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.